Back
Banco Santander Chile Vs. Sarepta Therapeutics Industry Stock Comparison
Sell
47
BSAC
Banco Santander Chile
Last Price:
$21.98
Seasonality Move:
-0.82%
Sell
38
SRPT
Sarepta Therapeutics
Last Price:
$106.94
Seasonality Move:
5.14%
Sell
47
Banco Santander Chile (BSAC)
is a Sell
Is Banco Santander Chile a Buy, Sell or Hold?
-
The current Banco Santander Chile [BSAC] share price is $21.81. The Score for BSAC is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
BSAC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
38
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $106.12. The Score for SRPT is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
-
SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BSAC Stock Price Chart
What is Banco Santander Chile's stock price today?
-
The Banco Santander Chile share price today is $21.81The current trend is moderately bullish and BSAC is experiencing selling pressure, which indicates risk of future bearish movement.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $106.12Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.
BSAC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.72 | Buy |
Relative Strength Index (14 RSI): | 59.89 | Buy |
Chaikin Money Flow: | -130535 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (19.84 - 22.12) | Buy |
Bollinger Bands (100): | (18.81 - 20.89) | Buy |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.32 | Sell |
Relative Strength Index (14 RSI): | 35.13 | Sell |
Chaikin Money Flow: | -665542 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (109.06 - 117.26) | Sell |
Bollinger Bands (100): | (113.14 - 127.52) | Sell |
BSAC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 22.21 | Sell |
20-day SMA: | 21.35 | Buy |
50-day SMA: | 19.94 | Buy |
200-day SMA: | 19.76 | Buy |
8-day EMA: | 22.03 | Sell |
20-day EMA: | 21.4 | Buy |
50-day EMA: | 20.48 | Buy |
200-day EMA: | 19.77 | Buy |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 107.99 | Sell |
20-day SMA: | 112.1 | Sell |
50-day SMA: | 118.2 | Sell |
200-day SMA: | 128.11 | Sell |
8-day EMA: | 108.31 | Sell |
20-day EMA: | 111.56 | Sell |
50-day EMA: | 116.18 | Sell |
200-day EMA: | 122.74 | Sell |
Banco Santander Chile Earnings Growth & BSAC Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, an increase next quarter of $0.03 per share, an increase this year of $0.24 per share, and an increase next year of $0.17 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.70 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.63 per share, and an increase next year of $4.84 per share.
Banco Santander Chile Technical Analysis
Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | Feb 18 | Feb 19 | Feb 20 | Feb 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
07 | 10 | 11 | 12 | 13 | 14 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | Feb 18 | Feb 19 | Feb 20 | Feb 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
07 | 10 | 11 | 12 | 13 | 14 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |